BCAX
Bicara Therapeutics Inc.
19.80$
-3.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -10.8% | +0.0% | +151.1% | +8.6% | -16.0% | -5.1% | -6.4% | +1.5% | +28.4% | -7.5% | |
| – | – | -10.8% | +0.0% | +153.1% | -3.6% | -6.3% | -5.6% | -33.1% | +41.9% | +29.1% | -7.5% | |
| – | – | -11.5% | +0.0% | +155.5% | -6.0% | -5.6% | -5.5% | -60.7% | -43.7% | +234.6% | -70.1% | |
| – | – | -11.5% | +0.0% | +155.5% | -6.0% | -5.6% | -5.5% | -33.5% | +43.0% | +30.1% | -7.9% | |
| – | – | +5.2% | +2,255.6% | -96.2% | +428.9% | -75.3% | -3.8% | +19.1% | +34.8% | +34.2% | +9.7% | |
| – | – | +6.5% | +0.0% | -9.9% | +24.2% | +6.3% | -9.9% | +22.1% | +37.7% | +35.9% | +10.5% | |
| – | – | +5.3% | +0.0% | +2.7% | +97.1% | -2.6% | +81.7% | +2.0% | +2.0% | +2.1% | +2.0% | |
| – | – | +47.0% | +0.0% | -58.1% | +129.8% | -39.2% | +6.2% | +25.8% | +112.8% | -4.5% | +13.7% | |
| – | – | -11.9% | -190.8% | – | -3.5% | -6.7% | -5.2% | -7.4% | -0.3% | +28.0% | -8.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.4% | +2.1% | +0.0% | +0.4% | +0.1% | +0.0% | +0.2% | +0.0% | +1.1% | +10.1% | +11.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.